A $3.5bn guarantee book and a $250bn commitment

TL;DR. A chip maker takes equity in the labs and cloud providers that buy its chips, and those companies use the capital to buy more of them. In 2024 it participated in more than 50 venture deals in AI, and it has announced more than $540 billion of such arrangements in the current year alone. The defence is straightforward and largely correct: in a market where advanced chips are scarce and buildouts are enormous, pairing long-term supply commitments with financing is ordinary industrial practice. The specific number worth checking is a filing. Its Q1 fiscal 2027 10-Q caps total lease-guarantee exposure at $3.5 billion, against a reported guarantee commitment of around $250 billion, roughly 71 times the disclosed book. The risk here is not fraud. It is that a slowdown in end-user demand would impair chip revenue, equity stakes and guarantee obligations simultaneously.

---

Status: established facts, contested interpretation. Deal terms, amounts and the 10-Q figure are from company announcements, filings and reporting. Analyst characterisations are attributed to the analysts who made them. This article is descriptive and is not investment advice. It makes no prediction about any company, security or market, and nothing here should be read as one.

---

The structure

A chip maker invests in an AI lab. The lab uses that capital, plus compute agreements with cloud providers, to buy chips. Most of those chips come from the same maker.

The documented sequence is specific.

December 2024: participation in xAI's $6 billion raise. September 2025: a $6.3 billion cloud-capacity agreement with CoreWeave, and backing for Mistral's €1.7 billion Series C. September 2025: a letter of intent to invest up to $100 billion in OpenAI as it deploys 10 gigawatts of systems. October 2025: participation in Nscale's $433 million round. November 2025: up to $15 billion committed alongside Microsoft to Anthropic, which pledged $30 billion in Azure spend. January 2026: a further $2 billion into CoreWeave. February 2026: the $100 billion OpenAI commitment is replaced by a $30 billion equity stake in a $110 billion round. March 2026: $2 billion into Nebius.

More than 50 venture deals in AI in 2024, on data from PitchBook, and a pace exceeding it since. More than $540 billion of such arrangements announced in the current year alone.

On the other side, OpenAI's named commitments include $250 billion to Azure, $300 billion to Oracle, $138 billion to AWS, $22.4 billion to CoreWeave, up to $100 billion to Nvidia and $10 billion to Broadcom, plus a multi-gigawatt AMD arrangement, across 2025 to 2035. Some tallies put the total past $1.1 trillion.

The defence, which is not weak

Jensen Huang has rejected the framing directly. On the CoreWeave investment: it is a small percentage of what those companies ultimately have to raise, and the idea that it is circular is, in his words, ridiculous.

The substantive version of that argument is strong. Building AI infrastructure is extraordinarily expensive and the most advanced chips are supply-constrained. In such a market, buyers do not simply place orders. They lock in supply by pairing long-term purchase commitments with financing, and suppliers underwrite customers who could not otherwise secure the capital.

This is ordinary industrial practice. It happens in aerospace, in shipping, in telecoms equipment, and in semiconductors historically. One asset manager describes the pattern as a virtuous circle aligning suppliers, builders and customers to meet demand that genuinely exists.

And the demand is not imaginary. CoreWeave reported $2.08 billion of Q1 2026 revenue, up 112% year on year, against a contracted backlog of $99.4 billion. Those are customers paying for compute.

The number in the filing

Here is the specific, checkable item, and it is the reason this article exists.

A reported arrangement would have the chip maker guarantee data centre debt, allowing a developer to borrow against its balance sheet rather than the lab's, since the lab lacks an investment-grade credit rating.

The company's Q1 fiscal 2027 10-Q caps total lease-guarantee exposure at $3.5 billion.

A commitment reported at around $250 billion would be roughly 71 times that disclosed book.

Nothing about that is concealed. The 10-Q figure is published; the commitment was announced. The point is that the two numbers come from the same company weeks apart and describe very different magnitudes of obligation, and a reader who has seen only one of them has an incomplete picture.

What the structure does to risk

The precise concern is not that anyone is being deceived. Every arrangement described here is disclosed.

It is that several exposures which look independent are not.

Chip revenue depends on customers buying chips. Equity stakes in those customers depend on the same customers being valuable. Guarantee obligations trigger if those customers cannot service debt.

All three move with one variable: end-user demand for AI. A slowdown would impair reported revenue, mark down the equity portfolio, and raise the probability of guarantees being called, at the same time and for the same reason.

That is correlated exposure, and it is a structural property rather than an accusation. It is precisely what diversification is supposed to prevent and precisely what this structure does not provide.

And the capex that moved

A related mechanism, less discussed and equally structural.

Microsoft has guided to around $190 billion of capital expenditure in 2026 against analyst forecasts of roughly $200 billion in operating cash flow. It has also used neocloud agreements to expand capacity, which converts capital expenditure into operating expense on its own statements.

The economic reality is unchanged. The spending has not disappeared; it has been transferred.

The entity absorbing it is a neocloud with $24.9 billion of debt and negative free cash flow. The entity distributing it across quarterly operating lines holds a top-tier credit rating.

From an aggregate view the transfer is visible in neocloud balance sheets. From a per-company view it is largely invisible, which is the scope problem applied to a balance sheet rather than a measurement.

Three things this establishes

Disclosed and legible are different properties. Every element here is public. Assembling them into a picture requires reading filings from several companies across several quarters, and almost nobody does. A structure can be fully transparent and still not understood.

Correlated exposure is the analytically precise concern. Not fraud, not a bubble prediction, not a claim that demand is fake. Simply that three exposures presented as distinct resolve to one variable, which matters regardless of what that variable does next.

And the strongest argument for the structure is also the strongest argument for watching it. Vendor financing is normal where supply is constrained and buildouts are large. It is also what preceded the late-1990s telecoms equipment episode, which is the comparison critics reach for and which supporters correctly note is not automatic.

What it does not establish

That the arrangements are improper. They are disclosed, and none of the analysts quoted here alleges misconduct.

That demand is illusory. A neocloud reporting 112% revenue growth against a $99.4 billion backlog has customers.

That any outcome follows. This article makes no prediction. Correlated exposure describes a structure, not a forecast, and the structure is compatible with the buildout succeeding.

And nothing about any security. No valuation claim is made or implied.

What is unresolved

Whether the guarantee commitment is finalised and on what terms. A reported arrangement and an executed one differ, and the gap between $3.5 billion of disclosed exposure and a $250 billion commitment is where the terms would matter most.

How much revenue is genuinely circular. Nobody has quantified the share of chip revenue that traces back to capital the chip maker supplied, and the disclosure required to do so does not exist.

Whether the neocloud model is durable. Negative free cash flow with a large backlog is either a financing timing problem or a business model problem, and the difference resolves over years.

And whether regulators take an interest. Vendor financing at this scale has attracted supervisory attention in other industries, and no equivalent action has been reported here.

The counter-argument

Chip revenue vastly exceeds the investment. The capital deployed is small relative to what the recipients raise elsewhere and small relative to the revenue in question, which is the substance of the company's own rebuttal. A structure is only circular in a meaningful sense if the circulating portion is material, and no published analysis establishes that it is.

Correlated exposure is the normal condition of a supplier. Every component maker's revenue, receivables and customer relationships move with its customers' fortunes. Calling that a special risk of this structure applies a standard no supplier meets, and equity stakes make explicit an exposure that already existed implicitly.

The 71x comparison mixes categories. A disclosed lease-guarantee book and a reported debt-guarantee commitment are different instruments with different triggers and terms. Dividing one by the other produces an arresting number and not necessarily a meaningful one, and this article leads with it.

And the telecoms comparison is doing unearned work. That episode involved financing customers who had no revenue for capacity nobody needed. The current buildout has paying customers and constrained supply, which is close to the opposite starting condition, and the analogy imports a conclusion rather than an argument.

The short version

A chip maker takes equity in the labs and clouds that buy its chips. More than 50 AI venture deals in 2024, and more than $540 billion of such arrangements announced this year. On the other side, one lab's named commitments run to $250 billion, $300 billion, $138 billion and more, with some tallies past $1.1 trillion.

The defence is largely correct. Where chips are scarce and buildouts are enormous, pairing supply commitments with financing is ordinary industrial practice, and the demand is real: one neocloud reported $2.08 billion of quarterly revenue, up 112%, against a $99.4 billion backlog.

The checkable number is a filing. The company's Q1 fiscal 2027 10-Q caps total lease-guarantee exposure at $3.5 billion, while a reported guarantee commitment runs around $250 billion, roughly 71 times it. Both figures are public, weeks apart, from the same company.

The concern is not fraud and not a forecast. It is that chip revenue, equity stakes and guarantee obligations all move with one variable: end-user demand for AI. A slowdown would impair all three at once and for the same reason. That is correlated exposure, which is a structural fact rather than an accusation.

And a related transfer runs alongside it. One hyperscaler guiding to roughly $190 billion of capex against about $200 billion of operating cash flow uses neocloud agreements that convert capital spending into operating expense. The spending has not disappeared. It has moved onto a balance sheet carrying $24.9 billion of debt and negative free cash flow, where it is visible in aggregate and largely invisible per company.

Common questions

What does "circular financing" mean here? A chip maker takes equity in AI labs and cloud providers, those companies use the capital together with compute agreements to buy chips, and most of the chips come from the same maker. Documented instances include participation in xAI's raise, a $6.3 billion cloud agreement with CoreWeave, investments in Mistral, Nscale and Nebius, a $30 billion equity stake in OpenAI, and up to $15 billion committed alongside Microsoft to Anthropic. More than 50 AI venture deals were made in 2024 and more than $540 billion of such arrangements have been announced this year.

Is this improper? No allegation of impropriety is made here and none of the analysts quoted alleges misconduct. Every arrangement described is disclosed. The substantive defence is that where advanced chips are supply-constrained and buildouts are enormous, buyers lock in supply by pairing long-term purchase commitments with financing, and suppliers underwrite customers who could not otherwise raise the capital. That is ordinary industrial practice with precedents in aerospace, shipping and semiconductors.

What is the $3.5 billion figure? The company's Q1 fiscal 2027 10-Q caps its total lease-guarantee exposure at $3.5 billion. A separately reported arrangement would have it guarantee data centre debt at around $250 billion, allowing a developer to borrow against its balance sheet rather than a lab's, since the lab lacks an investment-grade credit rating. That is roughly 71 times the disclosed guarantee book. Both numbers are public and come from the same company weeks apart.

Does the 71x comparison hold up? It is arresting and it mixes categories, which is the strongest objection to this article's framing. A disclosed lease-guarantee book and a reported debt-guarantee commitment are different instruments with different triggers and terms, so dividing one by the other produces a ratio that may not be meaningful. What survives the objection is narrower: the disclosed exposure and the reported commitment differ by orders of magnitude, and a reader who has seen only one has an incomplete picture.

What is the actual risk being described? Correlated exposure. Chip revenue depends on customers buying chips; equity stakes depend on those customers being valuable; guarantee obligations trigger if those customers cannot service debt. All three move with end-user demand for AI, so a slowdown would impair revenue, mark down the equity portfolio and raise the probability of guarantees being called simultaneously and for the same reason. That is a structural property, not an accusation and not a prediction.

Is the demand real? On the available evidence, yes. CoreWeave reported $2.08 billion of Q1 2026 revenue, up 112% year on year, against a contracted backlog of $99.4 billion. Those are customers paying for compute. The circularity question concerns how the buildout is financed, not whether anyone wants the output.

What is the capex transfer? One hyperscaler has guided to roughly $190 billion of capital expenditure in 2026 against analyst forecasts of about $200 billion in operating cash flow, while also using neocloud agreements to expand capacity. Those agreements convert capital expenditure into operating expense on its own statements. The economic reality is unchanged: the spending has moved onto a neocloud balance sheet carrying $24.9 billion of debt and negative free cash flow. It is visible in aggregate and largely invisible company by company.

How does this compare to the late-1990s telecoms episode? It is the comparison critics reach for and it does more work than it has earned. That episode involved financing customers with no revenue to build capacity nobody needed. The current buildout has paying customers, constrained supply and large contracted backlogs, which is close to the opposite starting condition. The comparison identifies a mechanism that has caused trouble before; it does not establish that the same outcome follows.